Storz Medical Magnetolith Emtt® Therapy

Remington Medical is the exclusive.  Magnetolith® distributor for Storz in Canada.

Extracorporeal Magnetotransduction Therapy (EMTT®) for regeneration and rehabilitation of musculoskeletal disorders

Extracorporeal Magnetotransduction Therapy (EMTT®) with the Storz MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or achilles tendon.

EMTT® differs from general forms of magnetic field therapy or PEMF due to the high oscillation frequency of 100 – 300 kHz.  EMTT® is 40% stronger than PEMF and enables a higher penetration depth of 18 cm working at a cellular and nerve level rather than only addressing muscles. Sessions of EMTT® can, therefore, treat a far wider range of indications when compared to PEMF.

Advantages of emtt®

Treatment with Magnetolith® is Comfortable and Straightforward

  • Magnetolith EMTT ® is easy to use, non-invasive and offers high patient comfort.

  • Patients can remain fully clothed throughout the treatment.

  • EMTT® can treat a wide range of MSK disorders.

  • Thanks to the articulated arm, EMTT® is a ‘touch-free’ treatment, perfectly suited for social distancing and minimal patient contact to reduce infection risk from non-symptomatic carriers of COVID-19.

  • Clinicians will not suffer from treatment fatigue as this is a hands-free treatment.

  • The treatments are quick; a typical session lasts between 5 – 20 minutes depending on the indication.

  • Magnetolith EMTT® does not require any special maintenance or technician to use and is low cost to run, providing your clinic maximum return on investment.

  • Reliable and long lasting equipment with water exchange needed only once every 6 months and applicator exchange every 2 years or 10 million pulseT

Typical indications

Magnetolith EMTT® is the only approved electromagnetic therapy for the treatment of  musculoskeletal diseases of the muscle, bone, joints, nerves, tendons and tissues. The effectiveness of electromagnetic transduction therapy in contributing to pain reduction for:

  • Degenerative joint diseases – Signs of wear and tear, e.g. arthrosis (knee, hip, hands, shoulder, elbow), herniated disc, spondylarthrosis
  • Pain therapy – (Chronic) pain, e.g. back pain, lumbalgia, tension, radiculopathies, heel pain
  • Sport injuries – (Chronic) inflammation of tendons and joints, tendon overload syndrome, osteitis pubis

How Does magnetolith emtt® differ from pulsed electromagnetic field (PEMF) ?

EMTT® differs from general forms of electromagnetic field therapy or PEMF due to its high oscillation frequency of 100 – 300 kHz.

EMTT® is 40% stronger than PEMF and enables a higher penetration depth of 18 cm working at a cellular and nerve level rather than only addressing muscles. Sessions of EMTT® can, therefore, treat a far wider range of indications when compared to PEMF.

Are there any side effects of EMTT®? 

EMTT® has no reported side effects. During the treatment the patient may experience mid discomfort and reddening of the skin. The short-lived discomfort the EMTT® treatment creates is just a minor in-convince and will be blinded when compared to the clinical relevant decrease of pain the patient receives.

EMTT ® Clinical Evidence & PDF'S

References of systematic reviews of significant therapeutic effects with STORZ MEDICAL EMTT® devices:

  • Andre Krath. et al., Journal of Orthopaedics, 14(3):410-415, 2017.

  • Electromagnetic transduction therapy in non-specific low back pain: A randomized clinical trial

  • Klüter, T. et al., Electromagnetic Biology and Medicine, 37(4):175-183, 2018.

  • Electromagnetic transduction therapy and shockwave therapy in 86 patients with rotator cuff tendinopathy: A prospective randomized controlled trial.

  • Gerdesmeyer, L. et al., The Journal for Foot and Ankle Surgery, 56(5):964-967, 2017.

  • Electromagnetic Transduction Therapy for Achilles Tendinopathy: A Preliminary Report on a New Technology.

  • Klüter, T. et al., Journal of Orthopedic Research and Therapy: JORT-1113. DOI: 10.29011/2575-8241.001113, 2018.

  • Electromagnetic Transduction Therapy in Patients with Chronic Aseptic Osteitis Pubis

  • Ringeisen, M., Ludger Gerdesmeyer., Presentation at the annual congress of the umbrella association osteology (DVO), March 2018, Dresden.

  • Therapy of traumatic/mechanical bone marrow edema with electromagneto-transduction therapy [in German].

  • Teresa Paolucci1 et al, Electromagnetic Field Therapy: A Rehabilitative Perspective in the Management of Musculoskeletal Pain – A Systematic Review, Journal of Pain Research, July 2020

Interested in the Magnetolith? Get in contact with an expert!

Please enter your details below and we'll contact you shortly.

Serving Canadians for over 35 Years

Have a question?
Scroll to Top